Print this Page Cushing's Message Boards

Current Clinical Trials

From NIH (July 12, 2008)

1 Recruiting Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma
Condition: Pituitary Adenoma
Intervention:
2 Recruiting Pituitary Tumor Surveillance: Pathogenic Correlation
Condition: Pituitary Tumor
Intervention:
3 Recruiting Temozolomide in Treating Patients With Invasive Pituitary Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Procedure: DNA methylation analysis; Procedure: gene expression profiling; Procedure: laboratory biomarker analysis; Procedure: protein expression analysis; Procedure: proteomic profiling
4 Recruiting Rosiglitazone in Treating Patients With Pituitary Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: rosiglitazone maleate
5 Recruiting An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Conditions: Abnormalities; Craniopharyngioma; Cushing's Syndrome; Endocrine Disease; Pituitary Neoplasm
Intervention:
6 Recruiting Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
Conditions: Healthy; Pituitary Disease; Thyroid Disease
Intervention: Drug: TRH (Thyrotropin Releasing Hormone)
7 Recruiting Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
Conditions: Growth Hormone Deficiency; Pituitary Tumor
Intervention:
8 Recruiting Effect of Diazoxide on the Obesity Secondary to Hypothalamic-Pituitary Lesions
Conditions: Hypothalamic-Pituitary Lesions; Craniopharyngiomas
Intervention: Drug: DIAZOXIDE
9 Recruiting Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing's Disease)
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: rosiglitazone maleate; Procedure: laboratory biomarker analysis
10 Recruiting Evaluation of Patients With Thyroid Disorders
Conditions: Hyperthyroidism; Hypothyroidism; Pituitary Neoplasm
Intervention:
11 Recruiting Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
Conditions: Acromegaly; Growth Hormone Deficiency; Pituitary Disease
Interventions: Drug: Somatropin; Drug: Placebo
12 Recruiting Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)
Conditions: Traumatic Brain Injury; Subarachnoid Hemorrhage; Hypopituitarism
Intervention:
13 Recruiting The Treatment and Natural History of Acromegaly
Conditions: Acromegaly; Pituitary Neoplasm
Intervention:
14 Recruiting Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland Macroadenoma
Condition: Acromegaly Associated With Pituitary Gland Macroadenoma
Intervention: Drug: Lanreotide autogel
15 Recruiting Does Topical Steroid Treatment Impair the Adrenal Function?
Conditions: Hypothalamus-Pituitary-Adrenal Axis Assessement; Topical Steroid Therapy in Chronic Skin Diseases
Intervention:
16 Recruiting Pituitary Derived-Intermedin is an Estrogen-Modulated Factor for Reducing Blood Pressure
Conditions: Menopause; Hypertension
Intervention: Behavioral: intermedin
17 Recruiting Genetics of Endocrine Tumours
Condition: Acromegaly
Intervention:
18 Recruiting Hypothalamus-Pituitary-Adrenal Axis and Use of Mifepristone for Psychotic Depression
Condition: Depression
Interventions: Drug: Mifepristone; Drug: Placebo
19 Recruiting Testosterone Gel Applied to Women With Pituitary Gland Problems
Condition: Panhypopituitarism
Intervention: Drug: Transdermal Testosterone gel
20 Recruiting Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors
Conditions: Hypopituitarism; Hypogonadism; Thyroid Dysfunction; Bone Diseases, Metabolic
Intervention:
21 Recruiting National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
Condition: Dwarfism, Pituitary
Intervention:
22 Recruiting Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)
Conditions: Dwarfism, Pituitary; Turner Syndrome
Intervention:
23 Recruiting Inter-Assay Growth Hormone and IGF-I Variability
Conditions: Acromegaly; Growth Hormone Deficiency
Intervention:
24 Recruiting A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands
Condition: Asthma
Interventions: Drug: FlutiForm 250/10 ug; Drug: FlutiForm 100/10 ug; Drug: Oral Prednisone 10mg; Drug: Placebo
25 Recruiting Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
Conditions: Turner Syndrome; Renal Insufficiency, Chronic; Pituitary Diseases; Dwarfism
Intervention: Drug: Somatropin (rDNA origin)
26 Recruiting Endocrine and Psychological Evaluation of Adopted Children
Condition: Psychosocial Adjustment
Intervention:
27 Recruiting Evaluation and Treatment of Neurosurgical Disorders
Condition: Neurologic Disorders
Intervention:
28 Recruiting Screening Patients With Central Nervous System Tumors for Participation in National Cancer Institute Clinical Trials
Conditions: Brain and Central Nervous System Tumors; Lymphoma
Interventions: Procedure: cytology specimen collection procedure; Procedure: physiologic testing
29 Recruiting Effects of Corticotropin Releasing Hormone (CRH) on the Sleep in Patients With Hypopituitarism
Condition: Hypopituitarism
Interventions: Other: corticotropin releasing hormone (CRH); Other: Placebo
30 Recruiting Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds
Condition: Psoriasis Vulgaris
Intervention: Drug: Calcipotriol plus hydrocortisone (LEO 80190)
31 Recruiting Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men
Condition: Aging
Intervention: Drug: anastrazole or dutasteride
32 Recruiting Endocrine Studies in Health and Disease
Condition: Endocrine Diseases
Intervention:
33 Recruiting New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Intervention:
34 Recruiting Hypothalamic-Pituitary-Adrenal (HPA) Axis in Psychotic Depression
Conditions: Psychotic Disorders; Depression; Depressive Disorder, Major
Intervention: Drug: Mifepristone
35 Not yet recruiting Cortisol Response to ACTH in Acute Stress
Condition: Aortic Aneurysm, Abdominal
Intervention: Drug: Adrenocorticotrophic hormone
36 Recruiting Antineoplaston Therapy in Treating Patients With Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10; Drug: antineoplaston AS2-1
37 Recruiting Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
Conditions: Kallmann Syndrome; Idiopathic Hypogonadotropic Hypogonadism
Intervention: Drug: gonadotropin releasing hormone (GnRH)
38 Recruiting Decreased Testosterone Levels in Men Over 65
Conditions: Aging; Hypogonadism; Andropause
Interventions: Drug: Anastrozole; Drug: Testosterone Gel
39 Recruiting Does Inhaled Busedonide or Fluticasone Impair Adrenal Function?
Condition: Adrenal Insufficency
Intervention:
40 Recruiting Does Intravitreal Injection of Triamcinolone Acetonide Impairs the Adrenal Function
Condition: Secondary Adrenal Insuffisency
Intervention:
41 Recruiting Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide acetate and cabergoline
42 Recruiting Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
Condition: Hypogonadism
Intervention: Drug: Ketoconazole, Dexamethesone, Androgel,GnRH
43 Recruiting Cutivate Lotion HPA Axis Pediatric Study
Condition: Atopic Dermatitis
Intervention: Drug: Fluticasone propionate 0.05% lotion
44 Recruiting Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
Conditions: Cushing's Syndrome; Hereditary Neoplastic Syndrome; Lentigo; Neoplasm; Testicular Neoplasm
Intervention:
45 Not yet recruiting Influence of Administration Route of Testosterone on Male Fertility
Condition: Hypogonadism
Interventions: Drug: MPP10, testosterone; Drug: Testosterone
46 Recruiting Pulsatile GnRH in Anovulatory Infertility
Conditions: Hypogonadotropic Hypogonadism; Amenorrhea; Kallman's Syndrome
Interventions: Drug: GnRH; Device: Mini-infusion pump
47 Recruiting Hydrocortisone in Patients of Out-of-Hospital Cardiac Arrest
Condition: Heart Arrest
Intervention: Drug: Hydrocortisone
48 Recruiting Effect of Race on Gonadotropin Responses
Condition: Premenopause
Interventions: Drug: Estradiol steroid infusion; Drug: Progesterone steroid infusion
49 Not yet recruiting Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine
Conditions: Schizophrenia; Hyperprolactinemia
Intervention: Drug: Bromocriptin
50 Recruiting Consequence of Lifetime Isolated Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: growth hormone administration for 6 months

51 Not yet recruiting Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States
Conditions: Acromegaly; Growth Hormone Deficiency
Intervention:
52 Recruiting Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
Condition: Acromegaly
Interventions: Drug: C2L-OCT-01 PR, 10 or 20 mg; Drug: C2L-OCT-01 PR, 20 mg
53 Recruiting A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: mifepristone
54 Recruiting Physiopathology of Sodium Retention in Acromegaly
Condition: Acromegaly
Intervention: Drug: furosemide
55 Recruiting Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
Conditions: Hypogonadism; Kallmann Syndrome; Puberty, Delayed; Puberty, Precocious; Hypothalamic Amenorrhea; Anosmia
Intervention:
56 Recruiting Characterizing Psychological Consequences of Childhood Trauma
Condition: Major Depressive Disorder
Interventions: Drug: DEX-CRF stimulation test; Behavioral: Psychosocial stress induction; Procedure: Brain imaging of sad mood , self-reference, reward; Behavioral: Acoustic startle
57 Recruiting Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome
Conditions: Cushing's Syndrome; Insulin Resistance
Intervention: Procedure: Surgery
58 Recruiting Exercise Amenorrhea Stress and Bone Health in Adolescents
Condition: Healthy
Intervention:
59 Recruiting Dexamethasone Treatment of Congenital Adrenal Hyperplasia
Condition: Adrenal Hyperplasia, Congenital
Intervention: Drug: dexamethasone
60 Recruiting Leuprolide in Determining the Cause of Gonadotropin Deficiency
Condition: Hypogonadism
Interventions: Drug: gonadotropin releasing hormone; Drug: leuprolide
61 Not yet recruiting Neuroendocrine Dysfunction in Traumatic Brain Injury: Correlation With Cognitive Dysfunction and Repair
Condition: Traumatic Brain Injury
Intervention:
62 Recruiting Study of Depression, Peptides, and Steroids in Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention:
63 Recruiting Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance
Conditions: Insulin Resistance; Hyperglycemia
Intervention: Drug: insulin-like growth factor I
64 Recruiting Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: Pasireotide
65 Recruiting Cardiovascular Risk Factors and LCH in Adults
Condition: Histiocytosis, Langerhans-Cell
Intervention:
66 Recruiting Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
Conditions: Polycystic Ovary Syndrome; Obstructive Sleep Apnea
Interventions: Device: continuous positive airway pressure (CPAP); Drug: depot leuprolide plus estrogen/progestin replacement; Drug: pioglitazone
67 Recruiting Involvement of Endogenous Digitalis-Like Compounds in Breast Cancer
Conditions: Breast Neoplasms; Fibrocystic Disease of Breast; Mammaplasty
Intervention:
68 Recruiting Study of GnRH (Gonadotropin Releasing Hormone) Treatment for Idiopathic Hypogonadotropic Hypogonadism (IHH)
Condition: Hypogonadism
Intervention: Drug: Gonadotropin Releasing Hormone (GnRH)
69 Recruiting Effects of Testosterone in Women With Depression
Condition: Depression
Intervention: Drug: Testosterone
70 Recruiting RU-486 in the Treatment of Bipolar Depression
Condition: Bipolar Depression
Intervention: Drug: mifepristone (RU-486)
71 Recruiting Prazosin to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse
Conditions: Cocaine Dependence; Alcohol Dependence
Interventions: Drug: Prazosin; Drug: placebo
72 Recruiting Obesity and Weight Loss on Reproductive Function
Condition: Obesity
Intervention:
73 Recruiting Baselines in Reproductive Disorders
Conditions: Amenorrhea; Hypogonadotropic Hypogonadism; Kallmann's Syndrome
Intervention: Procedure: Frequent baseline blood sampling
74 Recruiting rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency
Condition: Insulin-Like Growth Factor-1 Deficiency
Interventions: Drug: somatropin; Drug: mecasermin and somatropin; Drug: mecasermin and somatropin; Drug: mecasermin and somatropin
75 Recruiting Adrenal Function in Critical Illness
Condition: Adrenal Insufficiency
Intervention:
76 Recruiting Feasibility Study Into the Contraceptive Effect of Estetrol
Condition: Healthy
Interventions: Drug: estetrol; Drug: estetrol; Drug: estetrol and desogestrel; Drug: estetrol and progesterone
77 Recruiting Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System Study
Condition: Healthy
Intervention: Drug: Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System
78 Recruiting Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse
Conditions: Cocaine Dependent; Alcohol Dependent
Interventions: Drug: Guanfacine; Drug: Placebo
79 Recruiting Pelvic Pain in Women With Endometriosis
Conditions: Endometriosis; Pelvic Pain; Healthy; Tubal Ligation
Intervention:
80 Not yet recruiting FHA: Metabolism and Stress Reactivity
Conditions: Anovulation; FHA; Eumenorrhea
Intervention:
81 Recruiting The Effect of Ethanol on Overnight Glucose Regulation in Type 2
Condition: Type 2 Diabetes, Insulin Requiring
Interventions: Other: oral ethanol, overnight; Other: IV ethanol; Other: soda water; Other: soda water
82 Recruiting Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Condition: Cushing's Syndrome
Intervention: Drug: Mifepristone
83 Recruiting Dexamethasone to Prevent Oral Chronic Graft-Versus-Host Disease
Condition: Graft vs Host Disease
Intervention: Drug: Dexamethasone 0.01% Solution
84 Recruiting Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer
Conditions: Thyroid Cancer; Differentiated Thyroid Carcinoma
Intervention: Drug: Lithium Carbonate
85 Recruiting Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues
Condition: Cocaine Dependence
Interventions: Drug: Progesterone; Drug: Placebo
86 Recruiting Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
Condition: Acromegaly
Intervention:
87 Recruiting Glucose Tolerance in Acromegaly: The Influence of GH-Excess on Glucose Metabolism and Insulin Resistance
Conditions: Acromegaly; Diabetes; Insulin Resistance; Impaired Glucose Tolerance
Intervention:
88 Recruiting Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism
Condition: Panhypopituitarism
Intervention: Drug: Transdermal Testosterone Gel
89 Recruiting Estrogen Treatment in Acromegalic Women
Condition: Acromegaly
Intervention: Drug: Alesse
90 Recruiting Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
Conditions: Growth Hormone Deficiency; Septo-Optic Dysplasia; Hypopituitarism
Intervention: Drug: Nutropin AQ
91 Recruiting Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery
Condition: Acromegaly
Intervention:
92 Recruiting Androgen Replacement Therapy in Women With Hypopituitarism
Condition: Hypopituitarism
Intervention: Drug: TheraDerm
93 Recruiting Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment
Conditions: Hyperprolactinemia; Insulin Resistance
Intervention: Drug: Cabergoline
94 Not yet recruiting Use of Somatostatin Analogue Therapy as Primary Medical Treatment of Acromegaly
Condition: Acromegaly
Intervention: Drug: Somatuline Autogel
95 Recruiting Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
Condition: Nephrogenic Diabetes Insipidus
Interventions: Drug: sildenafil; Drug: calcitonin; Drug: hydrochlorothiazide/amiloride; Drug: indomethacin; Drug: Placebo for sildenafil; Drug: placebo for calcitonin
96 Recruiting Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
Condition: Acromegaly
Intervention:
97 Recruiting Endometriosis Patients Undergoing Quinagolide Treatment
Conditions: Hyperprolactinemia; Endometriosis
Intervention: Procedure: ENDOMETRIAL BIOPSY
98 Recruiting Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
Conditions: Acromegaly; Heart Failure; Hypertrophy, Left Ventricular
Intervention: Drug: pegvisomant
99 Not yet recruiting Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
Conditions: Hyperprolactinemia; Weight Gain; Dyslipidemia
Intervention: Drug: Abilify (aripiprazole)
100 Not yet recruiting Open Label Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel 120 mg in Acromegalic Subjects Who Are Biochemically Controlled on Long Term Treatment With Octreotide LAR 10 or 20 mg
Condition: Acromegaly
Intervention: Drug: Lanreotide Autogel 120 mg

101 Recruiting Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
Condition: Acromegaly
Intervention: Drug: C2L-OCT-01 PR 30 mg
102 Recruiting Ultrasound Guided Sandostatin LAR Injection in Acromegaly
Condition: Acromegaly
Interventions: Drug: Sandostatin LAR; Drug: Sandostatin LAR
103 Recruiting Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment
Conditions: Acromegaly; Growth Hormone; Insulin Resistance
Intervention: Procedure: Transsphenoidal adenomectomy
104 Recruiting Co-Treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-Responsive Acromegalic Patients
Conditions: Acromegaly; Insulin Resistance; Impaired Glucose Tolerance
Interventions: Drug: Pegvisomant; Drug: Somatostatin analog (Lanreotid or Octreotid)
105 Recruiting Testosterone and Growth Hormone for Bone Loss in Men
Conditions: Hypopituitarism; Hypogonadism; Growth Hormone Deficiency
Interventions: Drug: Testosterone plus somatropin; Drug: testosterone
106 Recruiting Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
Condition: Acromegaly
Intervention: Drug: Pasireotide

 

From NIH (7/10/2008)

1 Recruiting Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)
Conditions: Adrenal Tumors; Adrenal Malignancies; Abnormal Hormonal Secretions; Electrolytes Abnormalities
Intervention: Other: Imaging, Adrenal acans
2 Not yet recruiting Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation
Conditions: Cardiopulmonary Arrest; Cardiac Arrest
Interventions: Drug: Vasopressin; Drug: Epinephrine
3 Recruiting Adrenal Suppression and Adrenal Recovery Induced by Megestrol Acetate
Condition: Adrenal Function
Intervention: Drug: megestrol acetate
4 Recruiting Low-Dose Epinephrine Infusion Tests in Adolescent and Pediatric Patients
Condition: Congenital Disorders
Intervention: Drug: Epinephrine
5 Recruiting Adrenal Function in Critical Illness
Condition: Adrenal Insufficiency
Intervention:
6 Recruiting Adrenal Insufficiency in Critical Emergencies in Digestive Diseases
Conditions: Digestive Diseases; Adrenal Insufficiency; Gastrointestinal Bleeding; Variceal Bleeding; Acute Pancreatitis
Intervention:
7 Recruiting Adrenal Function in Patients With Newly Diagnosed Lung Cancer
Conditions: Lung Cancer; Adrenal Insufficiency
Intervention:
8 Recruiting Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis
Conditions: Sepsis; Adrenal Insufficiency
Intervention: Drug: Fludrocortisone
9 Recruiting Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia
Conditions: Congenital Adrenal Hyperplasia; 21-Hydroxylase Deficiency; Adrenogenital Syndrome
Intervention: Drug: Chronocort for the treatment of CAH
10 Recruiting Comparing Vasopressin and Adrenaline in Patients With Cardiac Arrest
Condition: Cardiac Arrest
Interventions: Drug: Vasopressin; Drug: Adrenaline
11 Recruiting Adrenal Tumors - Pathogenesis and Therapy
Conditions: Adrenal Tumors; Adrenocortical Carcinoma; Cushing Syndrome; Conn Syndrome; Pheochromocytoma
Intervention:
12 Recruiting Adrenal Function After Living Kidney Donation
Conditions: Addison Disease; Hypoaldosteronism
Intervention: Procedure: Laparoscopic hand-assisted donor nephrectomy
13 Recruiting Study of Adrenal Gland Tumors
Condition: Adrenal Gland Neoplasm
Intervention:
14 Recruiting Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia
Condition: Adrenal Hyperplasia, Congenital
Intervention: Drug: Hydrocortisone sodium acetate
15 Recruiting Qualitative Research on Women With Congenital Adrenal Hyperplasia
Conditions: Adrenal Hyperplasia, Congenital; Psychosexual Development; Sexual Development; Intersex; Congenital Adrenal Hyperplasia
Intervention: Other: Interview
16 Recruiting Dexamethasone Treatment of Congenital Adrenal Hyperplasia
Condition: Adrenal Hyperplasia, Congenital
Intervention: Drug: dexamethasone
17 Recruiting Does Topical Steroid Treatment Impair the Adrenal Function?